Research Triangle Park, NC - 10 April 2010

Qualyst will host a scientific seminar at the Hotel Marlowe in Cambridge, MA from 5:30 - 8:30pm on Wednesday, 28 April 2010 focusing on the use of its proprietary B-CLEAR assay to support drug discovery activities. Scientists from Pfizer (Groton, CT) and Novartis Institutes for BioMedical Sciences (Cambridge, MA) will describe specific programs and use of B-CLEAR to drive decision-making in their organizaitons. Immediately after the scientific discussions, Qualyst will host a reception for its guests and will be able to answer questions on other applications of the technology--specifically those driven by the recent International Transporter Consortium's "white paper" on the study of drug transporters.

AGENDA (28 April 2010)

5:30 - 6:00pm Welcome Reception

6:00 - 6:20pm David Duignan, Pfizer, Inc. (Groton, CT)

6:20 - 6:40pm Guoyu Pan, Novartis Institutes for BioMedical Sciences (Cambridge, MA)

6:40 - 7:00pm Kenneth Brouwer, Qualyst, Inc. (Research Triangle Park, NC)

7:00 - 8:30pm Hosted Reception with Heavy Hors D'Oeuvres

RSVP for this Event

Marc Sedam, Operations, (919) 313-6511, marcsedam@qualyst.com

About Qualyst, Inc.
Qualyst commercializes novel and proprietary drug transporter technologies which provide useful, actionable data. Qualyst's products allow pharmaceutical and biotechnology researchers to make faster, better decisions regarding drug candidate compounds, saving valuable time and research dollars in the process. Qualyst, Inc. was founded on discoveries from breakthrough research at the University of North Carolina at Chapel Hill in 2001. For additional information, please refer to the company's web site at www.qualyst.com or call 919-313-6500.